Literature DB >> 29693870

MPV, NLR, and platelet count: new hematologic markers in diagnosis of malignant ovarian tumor.

E Yilmaz, E I Coskun, N Sahin, B Ciplak, K Ekici.   

Abstract

OBJECTIVE: Evaluation of mean platelet volume (MPV), neutrophil to lymphocyte ratio (NLR), and platelet count in the detection of malignant and benign ovarian tumors.
MATERIAL AND METHODS: Sixty-six patients admitted to the present clinic over three years were in- cluded in the study. Patients diagnosed with ovarian cancer were grouped into the areas of epithelial and granulosa cell tumor diagno- sis. The values were compared to patients with benign cystic structure. Patients' preoperative hematologic parameters and their values four weeks postoperatively were analyzed. Statistical analyses were performed with SPSS software.
RESULTS: MPV, NLR, and platelet count were observed at a higher rate as statistically significant in patients diagnosed with malignant ovarian cancer, compared to those with benign adnexal mass.
CONCLUSION: The hemnatological parameters such as MPV, NLR, and platelet count in the detection of malignant ovarian tumors have been evaluated as useful new markers.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29693870

Source DB:  PubMed          Journal:  Eur J Gynaecol Oncol        ISSN: 0392-2936            Impact factor:   0.196


  4 in total

1.  Neutrophil-Lymphocyte and Platelet-Lymphocyte Ratios in Preoperative Differential Diagnosis of Benign, Borderline, and Malignant Ovarian Tumors.

Authors:  Tae Hui Yun; Yoon Young Jeong; Sun Jae Lee; Youn Seok Choi; Jung Min Ryu
Journal:  J Clin Med       Date:  2022-03-01       Impact factor: 4.241

Review 2.  Platelets: The Emerging Clinical Diagnostics and Therapy Selection of Cancer Liquid Biopsies.

Authors:  Yiming Meng; Jing Sun; Yang Zheng; Guirong Zhang; Tao Yu; Haozhe Piao
Journal:  Onco Targets Ther       Date:  2021-05-25       Impact factor: 4.147

3.  Lymphocyte-to-Monocyte Ratio is Associated with the Poor Prognosis of Breast Cancer Patients Receiving Neoadjuvant Chemotherapy.

Authors:  Youzhao Ma; Jingyang Zhang; Xiuchun Chen
Journal:  Cancer Manag Res       Date:  2021-02-16       Impact factor: 3.989

4.  Survival and prognostic analysis of preoperative indicators in patients undergoing surgical resections with rhabdomyosarcoma.

Authors:  Hongyu Jin; Man Zhang; Hui Zhou; Shiyu Zhu; Chenggong Hu
Journal:  Medicine (Baltimore)       Date:  2020-10-23       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.